Publications Office of the EU
Poland-Białystok: Pharmaceutical products - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Poland-Białystok: Pharmaceutical products

  • Published
    26/01/2022
  • Deadline
    25/02/2022
  • Awarded
    18/05/2022
  • Today
    17/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Uniwersytecki Szpital Kliniczny w Białymstoku
Place of performance
NUTS code: PL841 Białostocki
Location of buyer
NUTS code: PL841 Białostocki
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
339,048.00 PLN
Total final contract value (excluding VAT)
78,618,146.99 PLN
Please consult each lot for details
Number of lots
396
Tender reference number
9/2022
Description

Przedmiotem zamówienia jest sukcesywna dostawa leków przez okres 12 miesięcy

Submission Method
Tenders or requests to participate must be submitted to:
Official name: Uniwersytecki Szpital Kliniczny w Białymstoku
National registration number: 000288610
Postal address: M. Skłodowskiej-Curie 24a
Town: Białystok
NUTS code: PL841
Postal code: 15-276
Country: POL
Main address: https://e-propublico.pl
Electronic via:
https://e-propublico.pl
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Check linked documents for details
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.